Financial indicators for Memphis Pharmaceuticals and Chemical Industries showed that the company's profits increased by 164% year-on-year during the last fiscal year. The company stated that it achieved profits amounting to EGP 504.92 million during the fiscal year from July 2024 to June 2025, compared to profits of EGP 191.45 million in the previous fiscal year. The company recorded sales of EGP 1.5 billion during the last fiscal year, compared to EGP 871.9 million in sales in the previous fiscal year. Memphis Pharmaceuticals and Chemical Industries achieved a net profit of EGP 375.75 million during the period from July to March 2025, compared to a net profit of EGP 166.36 million during the same period of the previous year.
